29 Apr 2026
22m

Q1 earnings take off, Lilly strikes deals, Regeneron notches historic approval, FDA raises questions

Podcast cover

BioSpace

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

Q1 earnings take off, Lilly strikes deals, Regeneron notches historic approval, FDA raises questions